Skip to main content
Journal Guides8 min readUpdated Jul 14, 2026

Cell Death and Differentiation Impact Factor

Cell Death and Differentiation impact factor is 13.6. See the current rank, quartile, and what the number actually means before you submit.

By Manusights Editorial Team
Editorial processThe Manusights editorial team researches and maintains our Oncology & Cell Biology guides, drawing on what we see across thousands of pre-submission manuscript reviews.How we work

Journal evaluation

Want the full picture on Cell Death and Differentiation?

See scope, selectivity, submission context, and what editors actually want before you decide whether Cell Death and Differentiation is realistic.

Open Cell Death and Differentiation GuideAnthropic Privacy Partner. Zero-retention manuscript processing.Run my Free Readiness Scan
Metric context

A fuller snapshot for authors

Use Cell Death and Differentiation's impact factor as one signal, then stack it against selectivity, editorial speed, and the journal guide before you decide where to submit.

Open full journal guide
Impact factor13.6Current JIF
Acceptance rateSelective Springer Nature cell-death journalOverall selectivity
First decisionEditorial screening firstProcess speed

What this metric helps you decide

  • Whether Cell Death and Differentiation has the citation profile you want for this paper.
  • How the journal compares to nearby options when prestige or visibility matters.
  • Whether the citation upside is worth the likely selectivity and process tradeoffs.

What you still need besides JIF

  • Scope fit and article-type fit, which matter more than a high number.
  • Desk-rejection risk, which impact factor does not predict.
  • Timeline and cost context.
Submission context

How authors actually use Cell Death and Differentiation's impact factor

Use the number to place the journal in the right tier, then check the harder filters: scope fit, selectivity, and editorial speed.

Use this page to answer

  • Is Cell Death and Differentiation actually above your next-best alternatives, or just more famous?
  • Does the prestige upside justify the likely cost, delay, and selectivity?
  • Should this journal stay on the shortlist before you invest in submission prep?

Check next

  • Acceptance rate and desk-rejection risk, because impact factor does not tell you if the journal is realistic.
  • First decision: Editorial screening first. Timeline matters if you are under a grant, job, or revision clock.
  • Publishing cost and article type, since those constraints can override prestige.

Quick answer: Cell Death & Differentiation has a 2025 Journal Impact Factor (JIF) of 13.6. Its official Nature journal-information page also lists a five-year JIF of 15.3, a 5-day median to first editorial decision, 6,788,667 downloads in 2025, print ISSN 1350-9047, and eISSN 1476-5403. Cite the number as a 2025 JIF released in 2026, then keep it separate from the question of whether a cell-death manuscript fits this journal.

Last reviewed: July 14, 2026. Evidence basis: Cell Death & Differentiation's official Nature profile and Clarivate JCR release context.

What Is The Cell Death And Differentiation Impact Factor At A Glance?

Metric or identifier
Current value
Evidence boundary
Journal Impact Factor
13.6 (2025 JIF)
Official Nature display
Five-year Journal Impact Factor
15.3 (2025)
Official Nature display
SNIP
2.944 (2025)
Official Nature display; not a JIF substitute
SJR
5.182 (2025)
Official Nature display; not a JIF substitute
Submission to first editorial decision
Median 5 days
Publisher aggregate; not a peer-review or acceptance promise
Submission to acceptance
Median 222 days
Publisher aggregate; not an individual timeline
Downloads
6,788,667 (2025)
Journal-level reach context
Print ISSN
1350-9047
Official Nature display
eISSN
1476-5403
Official Nature display
Publisher
Springer Nature
Official Nature display

The 13.6 JIF is the current two-year citation-window measure on the

publisher's journal page. The 15.3 five-year JIF uses a longer citation

window. They are not interchangeable, and neither predicts a particular

paper's citations, editorial outcome, or scientific importance.

For formal promotion, funding, or institutional reporting, follow the

bibliometric route required by that institution. This page records the current

public publisher display and exact journal identifiers; it is not a licensed

Journal Citation Reports export.

Is This The Exact Cell Death And Differentiation Journal?

The exact title uses an ampersand: Cell Death & Differentiation. It is a

Springer Nature journal in cell and molecular biology. The publisher lists

print ISSN 1350-9047 and eISSN 1476-5403.

Do not copy this value to Cell Death & Disease, Cell Death Discovery, or

another journal in the CDDpress family. Similar titles can share topics yet

have different article mixes, scopes, identifiers, and journal metrics. Use

this exact-record check before citing a number from a directory or a cached

search result.

Verify before citing
Match
Why it matters
Journal title
Cell Death & Differentiation
Avoids a CDDpress sibling substitution
Print ISSN
1350-9047
Confirms the serial record
Electronic ISSN
1476-5403
Confirms the online serial record
JIF data year
2025
Identifies the citation year used for the JIF
Release context
2026
Avoids calling it a 2026 citation-year metric
Source
Current Nature journal-information page
Keeps the lookup tied to a primary publisher record

Cell Death And Differentiation Impact Factor Trend: Source Boundary

The official Nature page checked for this guide presents the current **2025

JIF of 13.6** and five-year JIF of 15.3. It does not provide a full

year-by-year JIF history on that page. A secondary record may appear in search

results with earlier values, but it is not enough to establish a publisher-

verified trend, a forecast, or a claim about why a value changed.

The safe statement is therefore narrow: the publisher currently displays a

2025 JIF of 13.6. Do not turn that snapshot into a chart, an increase-or-

decrease claim, or a prediction about the next JCR release without a source

that identifies each data year and its provenance.

Question
What the current primary record supports
What it does not support
Current JIF
13.6 for 2025
A multi-year history
Five-year JIF
15.3 for 2025
A claim that the longer window is "better"
Reach
6,788,667 downloads in 2025
Citation count for an individual paper
Speed
Publisher medians of 5 and 222 days
A promise for one submission

How Should The 13.6 JIF And 15.3 Five-Year JIF Be Read?

The two figures are journal-level citation windows, not a scorecard for an

individual manuscript. Clarivate describes the Journal Impact Factor as a

journal metric calculated from citations in the JCR year to eligible content

from the preceding two years. The five-year version uses a longer publication

window. They can give context about a journal record, but they do not prove

that the paper in front of an editor has enough evidence or belongs with this

audience.

Decision
Better evidence than a JIF alone
Why it matters
Is this the exact journal?
Title and both ISSNs
Prevents a title-family collision
Is the metric current?
2025 JIF plus 2026 release context
Keeps metric and release years distinct
Does the paper fit?
Current scope, mechanism question, evidence, and intended readers
Citation averages cannot determine editorial fit
Is a deadline workable?
Current author guidance and the actual deadline
A median is not a personal publication plan
Is a claim persuasive?
Study design, causal evidence, analysis, and limitations
Journal metrics cannot validate a biological conclusion

Named Failure Pattern: CDDpress Sibling Substitution

The main lookup error is CDDpress sibling substitution: a reader sees a

plausible value for Cell Death & Disease or Cell Death Discovery and assumes

it belongs to Cell Death & Differentiation. The practical prevention is small

but auditable: match the exact title, both ISSNs, the data year, release

context, and publisher source before repeating a metric.

A second error is citation-year drift. A metric displayed after the 2026

release can be casually called a "2026 impact factor" even when the publisher

labels it as a 2025 JIF. Describe it precisely as a **2025 JIF of 13.6,

released in 2026** when that distinction matters.

The third error is metric-to-manuscript inference. A journal citation

average does not establish whether an in-vitro result is causal, whether a

claimed death mode is demonstrated with appropriate orthogonal evidence, or

whether a differentiation result has the scope the journal expects. Those are

manuscript and editorial questions, not answers contained in a JIF.

What Does The Publisher Source Establish, And What Does It Not Establish?

The official Nature record establishes a current snapshot: Cell Death &

Differentiation has a 2025 JIF of 13.6, five-year JIF of 15.3, SNIP of 2.944,

SJR of 5.182, 5-day median first editorial decision, 222-day median submission

to acceptance, and the publisher-reported 2025 download figure.

It does not establish an acceptance rate, article processing charge, quartile,

category rank, historical JIF series, fee, or likely decision for one paper.

Those are separate facts that need their own current primary sources. SNIP and

SJR also must not be relabeled as JIF: they are distinct metrics with distinct

methods.

For a cell-death manuscript, the important work remains manuscript-level:

define the biological question, distinguish observation from causal mechanism,

show that the experimental system supports the claim, document analysis and

replication, and calibrate the conclusion. A journal metric cannot make those

judgments for an author.

How Should The Publisher Timing Figures Be Used?

The official profile reports a median **5 days from submission to first

editorial decision and 222 days from submission to acceptance**. These are

historical journal aggregates. They do not mean every paper receives peer

review within five days, that a revision will be invited, or that publication

will meet a thesis, funding, or clinical deadline. Editor assignment, reviewer

availability, the need for new evidence, revision rounds, and production all

vary by paper.

Use current author instructions for the next submission action. If the open

question is whether your evidence package fits the journal's mechanism-first

scope, a Cell Death & Differentiation submission readiness check assesses the manuscript-level question; a JIF does not.

What Pre-Submission Reviews Reveal About CDD-Fit Decisions

Mechanism claimed from a descriptive signal. A marker change, expression

association, or one intervention can be important, but it may not establish

the causal death or differentiation mechanism stated in the abstract. Align

the claim with the strongest evidence and make the limit visible.

Mode-of-death evidence treated as interchangeable. Cell-death claims need

evidence that distinguishes the claimed process from alternatives. A result

that is compatible with one mechanism is not automatically proof of it.

Timing aggregate treated as a decision forecast. The publisher's 5-day and

222-day medians describe prior journal handling, not whether a specific

submission clears scope, peer review, revision, or acceptance.

These are Manusights pre-submission checks derived from the publisher's public

scope and metric context, not claims about confidential editorial rules. The

existing Cell Death & Differentiation submission guide owns the article package and fit mechanics; the response-to-reviewers guide owns the post-decision revision job.

Why This Exact-Record Page Exists

This page was created by the Manusights editorial team after checking the

current publisher record. It helps when the decision is whether a displayed

number belongs to the exact Cell Death & Differentiation title and whether it

is a JIF, another bibliometric measure, or a timing aggregate. The page is a

verification aid, not a replacement for the official source.

It owns only the Cell Death & Differentiation impact-factor lookup. It does

not own submission mechanics, response letters, fees, under-review status,

acceptance rates, or broad cell-biology journal selection. That boundary keeps

it distinct from the journal's existing submission and revision owners.

For the broader journal record, use Cell Death & Differentiation. It is a distinct scope and navigation resource, not a source that changes the metric reported here.

What Should Authors Verify Before Citing The Metric?

  • Match Cell Death & Differentiation, print ISSN 1350-9047, and eISSN 1476-5403.
  • Describe 13.6 as a 2025 JIF, released in 2026.
  • Keep the five-year JIF of 15.3 distinct from the two-year JIF.
  • Keep SNIP 2.944 and SJR 5.182 distinct from either JIF.
  • Use the primary Nature profile for a current public lookup and the required JCR route for formal bibliometrics.
  • Verify scope, article type, fees, and policies in current author guidance because they are separate from a metric lookup.

For broader journal selection, use the best cell biology journals guide and the how to choose a journal guide. They answer different reader jobs and should not compete for this exact metric query.

Submit If

  • You need a current exact-title Cell Death & Differentiation JIF with a primary-source boundary.
  • You need to distinguish JIF, five-year JIF, SNIP, SJR, and timing aggregates.
  • You need a present metric snapshot rather than a speculative historical trend or acceptance prediction.

Think Twice If

  • The target is another CDDpress title and its exact name or ISSN has not been checked.
  • A journal-level citation number is being used as evidence that one paper will be accepted, reviewed on a fixed schedule, or cited at a particular rate.
  • A formal rank, quartile, fee, acceptance rate, or historical trend is required but is not established by the primary source used here.

Bottom Line

Cell Death & Differentiation's official current profile gives a **2025 Journal

Impact Factor of 13.6 and a five-year JIF of 15.3**. Confirm the exact

title and ISSNs, label the 2025 citation year and 2026 release context

correctly, and separate journal metrics from a manuscript-fit decision.

Frequently asked questions

Cell Death & Differentiation has a 2025 Journal Impact Factor of 13.6 on its official Nature journal-information page. The metric year is 2025 and the JIF release is in 2026.

The official Nature profile lists a five-year Journal Impact Factor of 15.3 for 2025. It uses a longer citation window than the current two-year JIF.

Cell Death & Differentiation has print ISSN 1350-9047 and electronic ISSN 1476-5403. Confirm the exact title and identifiers before reusing any metric.

No. The JIF is a journal-level citation metric. A manuscript still needs an appropriate cell-death or differentiation question, evidence, scope fit, and editorial assessment.

References

Sources

  1. Cell Death & Differentiation official journal information
  2. Springer Nature explanation of journal metrics
  3. Clarivate Journal Citation Reports

Before you upload

Want the full picture on Cell Death and Differentiation?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next